Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Lazard Stories

2012-11-06 16:28:38

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Lazard Capital Markets 9(th) Annual Healthcare Conference in New York on Tuesday, November 13, 2012 at 1:30 p.m. PT/4:30 p.m. ET. Kurt Gustafson, Chief Financial Officer, Halozyme Therapeutics, will provide a corporate overview. (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO) The presentation will be webcast through the "Investors" section of Halozyme's corporate...

2012-11-06 16:28:04

MINNEAPOLIS, Nov. 6, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in two upcoming investor conferences in November - the Stephens Fall Investment Conference and the Lazard 9(th) Annual Healthcare Conference. Detailed information is provided below: What: Stephens Fall Investment...

2012-11-06 16:27:45

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the upcoming Lazard Capital Markets 9(th) Annual Healthcare Conference in New York and the Jefferies 2012 Global Healthcare Conference in London. On Tuesday, November 13, Harry F. Hixson Jr., Ph.D., Sequenom's Chief Executive Officer, will present at the Lazard Capital Markets...

2012-11-06 08:28:53

ATLANTA, Nov. 6, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present in the upcoming Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 3:00 pm ET in New York City. CryoLife's live presentation may be accessed through its Web site,...

2012-11-06 08:27:51

MENLO PARK, Calif., Nov. 6, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Lazard Capital Markets 9(th) Annual Healthcare Conference in New York City. The presentation at the Lazard conference is scheduled for 10:30 am EST (7:30 am PST) on Wednesday, November 14, 2012. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the...

2012-11-05 20:23:35

WASHINGTON, Nov. 5, 2012 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will deliver a corporate presentation at the Lazard Healthcare Conference in New York City on Wednesday, November 14, 2012 at 3:00 p.m. Eastern Time. The presentation at the Lazard Healthcare Conference will be webcast live on...

2012-10-04 06:26:54

LA JOLLA, Calif., Oct. 4, 2012 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the pricing of its initial public offering of 11,250,000 shares of its common stock at $4.00 per share. Regulus has also granted the underwriters a 30-day option to purchase up to an additional 1,687,500 shares at the initial public offering price to cover overallotments, if any....

2012-09-12 02:29:28

SAN DIEGO, Sept. 12, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Lazard Capital Markets Corporate Access Day in Boston, Mass., and the Credit Suisse 3(rd) Annual Small and Mid-Cap Conference, in New York. On Tuesday, September 18, Ronald M. Lindsay, Ph.D., Director and EVP of Research and Development, will participate in the Lazard...

2012-09-11 10:25:02

YOKNEAM, Israel, Sept. 11, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today that Louis P. Scafuri, Chief Executive Officer, is scheduled to participate at two upcoming investor conferences. (Logo: http://photos.prnewswire.com/prnh/20120528/535447 ) The first conference is the Lazard Capital Markets Corporate Access Day in Boston. This conference will allow institutional investors to meet with Syneron but does not include...

2012-08-20 02:30:05

LA JOLLA, Calif., Aug. 20, 2012 /PRNewswire/ -- Regulus Therapeutics Inc., a biopharmaceutical company founded by Alnylam Pharmaceuticals (NASDAQ: ALNY) and Isis Pharmaceuticals (NASDAQ: ISIS), announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by Regulus. The number...